0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-27O290
Home | Market Reports | Science| Biological Sciences| Neuroscience
Global Metabotropic Glutamate Receptor 5 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Metabotropic Glutamate Receptor 1 Market Research Report 2025

Code: QYRE-Auto-27O290
Report
January 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Metabotropic Glutamate Receptor 1 Market

The global market for Metabotropic Glutamate Receptor 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Metabotropic Glutamate Receptor 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Metabotropic Glutamate Receptor 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Metabotropic Glutamate Receptor 1 include Aevi Genomic Medicine Inc, Biohaven Pharmaceutical Holding Company Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor 1.
The Metabotropic Glutamate Receptor 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metabotropic Glutamate Receptor 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabotropic Glutamate Receptor 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Metabotropic Glutamate Receptor 1 Market Report

Report Metric Details
Report Name Metabotropic Glutamate Receptor 1 Market
Segment by Type
  • FC-311
  • JBPOS-0101
  • VU-0467558
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aevi Genomic Medicine Inc, Biohaven Pharmaceutical Holding Company Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Metabotropic Glutamate Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Metabotropic Glutamate Receptor 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Metabotropic Glutamate Receptor 1 Market report?

Ans: The main players in the Metabotropic Glutamate Receptor 1 Market are Aevi Genomic Medicine Inc, Biohaven Pharmaceutical Holding Company Ltd

What are the Application segmentation covered in the Metabotropic Glutamate Receptor 1 Market report?

Ans: The Applications covered in the Metabotropic Glutamate Receptor 1 Market report are Depression, DiGeorge Syndrome, Infantile Spasm, Others

What are the Type segmentation covered in the Metabotropic Glutamate Receptor 1 Market report?

Ans: The Types covered in the Metabotropic Glutamate Receptor 1 Market report are FC-311, JBPOS-0101, VU-0467558, Others

Recommended Reports

Receptor and Antibody Markets

Neurotherapeutics & CNS

Advanced Therapy Technologies

1 Metabotropic Glutamate Receptor 1 Market Overview
1.1 Product Definition
1.2 Metabotropic Glutamate Receptor 1 by Type
1.2.1 Global Metabotropic Glutamate Receptor 1 Market Value Comparison by Type (2024 VS 2031)
1.2.2 FC-311
1.2.3 JBPOS-0101
1.2.4 VU-0467558
1.2.5 Others
1.3 Metabotropic Glutamate Receptor 1 by Application
1.3.1 Global Metabotropic Glutamate Receptor 1 Market Value by Application (2024 VS 2031)
1.3.2 Depression
1.3.3 DiGeorge Syndrome
1.3.4 Infantile Spasm
1.3.5 Others
1.4 Global Metabotropic Glutamate Receptor 1 Market Size Estimates and Forecasts
1.4.1 Global Metabotropic Glutamate Receptor 1 Revenue 2020-2031
1.4.2 Global Metabotropic Glutamate Receptor 1 Sales 2020-2031
1.4.3 Global Metabotropic Glutamate Receptor 1 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metabotropic Glutamate Receptor 1 Market Competition by Manufacturers
2.1 Global Metabotropic Glutamate Receptor 1 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Metabotropic Glutamate Receptor 1 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metabotropic Glutamate Receptor 1, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Product Type & Application
2.7 Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Date of Enter into This Industry
2.8 Global Metabotropic Glutamate Receptor 1 Market Competitive Situation and Trends
2.8.1 Global Metabotropic Glutamate Receptor 1 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Metabotropic Glutamate Receptor 1 Players Market Share by Revenue
2.8.3 Global Metabotropic Glutamate Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metabotropic Glutamate Receptor 1 Market Scenario by Region
3.1 Global Metabotropic Glutamate Receptor 1 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metabotropic Glutamate Receptor 1 Sales by Region: 2020-2031
3.2.1 Global Metabotropic Glutamate Receptor 1 Sales by Region: 2020-2025
3.2.2 Global Metabotropic Glutamate Receptor 1 Sales by Region: 2026-2031
3.3 Global Metabotropic Glutamate Receptor 1 Revenue by Region: 2020-2031
3.3.1 Global Metabotropic Glutamate Receptor 1 Revenue by Region: 2020-2025
3.3.2 Global Metabotropic Glutamate Receptor 1 Revenue by Region: 2026-2031
3.4 North America Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country
3.4.1 North America Metabotropic Glutamate Receptor 1 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metabotropic Glutamate Receptor 1 Sales by Country (2020-2031)
3.4.3 North America Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country
3.5.1 Europe Metabotropic Glutamate Receptor 1 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metabotropic Glutamate Receptor 1 Sales by Country (2020-2031)
3.5.3 Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metabotropic Glutamate Receptor 1 Market Facts & Figures by Region
3.6.1 Asia Pacific Metabotropic Glutamate Receptor 1 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metabotropic Glutamate Receptor 1 Sales by Region (2020-2031)
3.6.3 Asia Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country
3.7.1 Latin America Metabotropic Glutamate Receptor 1 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metabotropic Glutamate Receptor 1 Sales by Country (2020-2031)
3.7.3 Latin America Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Metabotropic Glutamate Receptor 1 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metabotropic Glutamate Receptor 1 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Metabotropic Glutamate Receptor 1 Sales by Type (2020-2031)
4.1.1 Global Metabotropic Glutamate Receptor 1 Sales by Type (2020-2025)
4.1.2 Global Metabotropic Glutamate Receptor 1 Sales by Type (2026-2031)
4.1.3 Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2020-2031)
4.2 Global Metabotropic Glutamate Receptor 1 Revenue by Type (2020-2031)
4.2.1 Global Metabotropic Glutamate Receptor 1 Revenue by Type (2020-2025)
4.2.2 Global Metabotropic Glutamate Receptor 1 Revenue by Type (2026-2031)
4.2.3 Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2020-2031)
4.3 Global Metabotropic Glutamate Receptor 1 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metabotropic Glutamate Receptor 1 Sales by Application (2020-2031)
5.1.1 Global Metabotropic Glutamate Receptor 1 Sales by Application (2020-2025)
5.1.2 Global Metabotropic Glutamate Receptor 1 Sales by Application (2026-2031)
5.1.3 Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2020-2031)
5.2 Global Metabotropic Glutamate Receptor 1 Revenue by Application (2020-2031)
5.2.1 Global Metabotropic Glutamate Receptor 1 Revenue by Application (2020-2025)
5.2.2 Global Metabotropic Glutamate Receptor 1 Revenue by Application (2026-2031)
5.2.3 Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application (2020-2031)
5.3 Global Metabotropic Glutamate Receptor 1 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aevi Genomic Medicine Inc
6.1.1 Aevi Genomic Medicine Inc Company Information
6.1.2 Aevi Genomic Medicine Inc Description and Business Overview
6.1.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product Portfolio
6.1.5 Aevi Genomic Medicine Inc Recent Developments/Updates
6.2 Biohaven Pharmaceutical Holding Company Ltd
6.2.1 Biohaven Pharmaceutical Holding Company Ltd Company Information
6.2.2 Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
6.2.3 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product Portfolio
6.2.5 Biohaven Pharmaceutical Holding Company Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metabotropic Glutamate Receptor 1 Industry Chain Analysis
7.2 Metabotropic Glutamate Receptor 1 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metabotropic Glutamate Receptor 1 Production Mode & Process Analysis
7.4 Metabotropic Glutamate Receptor 1 Sales and Marketing
7.4.1 Metabotropic Glutamate Receptor 1 Sales Channels
7.4.2 Metabotropic Glutamate Receptor 1 Distributors
7.5 Metabotropic Glutamate Receptor 1 Customer Analysis
8 Metabotropic Glutamate Receptor 1 Market Dynamics
8.1 Metabotropic Glutamate Receptor 1 Industry Trends
8.2 Metabotropic Glutamate Receptor 1 Market Drivers
8.3 Metabotropic Glutamate Receptor 1 Market Challenges
8.4 Metabotropic Glutamate Receptor 1 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Metabotropic Glutamate Receptor 1 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Metabotropic Glutamate Receptor 1 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Metabotropic Glutamate Receptor 1 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Metabotropic Glutamate Receptor 1 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Metabotropic Glutamate Receptor 1 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Metabotropic Glutamate Receptor 1 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Metabotropic Glutamate Receptor 1 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Metabotropic Glutamate Receptor 1, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Product Type & Application
 Table 12. Global Key Manufacturers of Metabotropic Glutamate Receptor 1, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Metabotropic Glutamate Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 1 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Metabotropic Glutamate Receptor 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Metabotropic Glutamate Receptor 1 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2020-2025)
 Table 19. Global Metabotropic Glutamate Receptor 1 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2026-2031)
 Table 21. Global Metabotropic Glutamate Receptor 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2020-2025)
 Table 23. Global Metabotropic Glutamate Receptor 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2026-2031)
 Table 25. North America Metabotropic Glutamate Receptor 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Metabotropic Glutamate Receptor 1 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Metabotropic Glutamate Receptor 1 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Metabotropic Glutamate Receptor 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Metabotropic Glutamate Receptor 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Metabotropic Glutamate Receptor 1 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Metabotropic Glutamate Receptor 1 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Metabotropic Glutamate Receptor 1 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Metabotropic Glutamate Receptor 1 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Metabotropic Glutamate Receptor 1 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Metabotropic Glutamate Receptor 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Metabotropic Glutamate Receptor 1 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Metabotropic Glutamate Receptor 1 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Metabotropic Glutamate Receptor 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Metabotropic Glutamate Receptor 1 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Metabotropic Glutamate Receptor 1 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Metabotropic Glutamate Receptor 1 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Metabotropic Glutamate Receptor 1 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2020-2025)
 Table 53. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2026-2031)
 Table 54. Global Metabotropic Glutamate Receptor 1 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Metabotropic Glutamate Receptor 1 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2020-2025)
 Table 57. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2026-2031)
 Table 58. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Metabotropic Glutamate Receptor 1 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Metabotropic Glutamate Receptor 1 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2020-2025)
 Table 63. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2026-2031)
 Table 64. Global Metabotropic Glutamate Receptor 1 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Metabotropic Glutamate Receptor 1 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application (2020-2025)
 Table 67. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application (2026-2031)
 Table 68. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Aevi Genomic Medicine Inc Company Information
 Table 71. Aevi Genomic Medicine Inc Description and Business Overview
 Table 72. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product
 Table 74. Aevi Genomic Medicine Inc Recent Developments/Updates
 Table 75. Biohaven Pharmaceutical Holding Company Ltd Company Information
 Table 76. Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
 Table 77. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product
 Table 79. Biohaven Pharmaceutical Holding Company Ltd Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Metabotropic Glutamate Receptor 1 Distributors List
 Table 83. Metabotropic Glutamate Receptor 1 Customers List
 Table 84. Metabotropic Glutamate Receptor 1 Market Trends
 Table 85. Metabotropic Glutamate Receptor 1 Market Drivers
 Table 86. Metabotropic Glutamate Receptor 1 Market Challenges
 Table 87. Metabotropic Glutamate Receptor 1 Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Metabotropic Glutamate Receptor 1
 Figure 2. Global Metabotropic Glutamate Receptor 1 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Metabotropic Glutamate Receptor 1 Market Share by Type: 2024 & 2031
 Figure 4. FC-311 Product Picture
 Figure 5. JBPOS-0101 Product Picture
 Figure 6. VU-0467558 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Metabotropic Glutamate Receptor 1 Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Metabotropic Glutamate Receptor 1 Market Share by Application: 2024 & 2031
 Figure 10. Depression
 Figure 11. DiGeorge Syndrome
 Figure 12. Infantile Spasm
 Figure 13. Others
 Figure 14. Global Metabotropic Glutamate Receptor 1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Metabotropic Glutamate Receptor 1 Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Metabotropic Glutamate Receptor 1 Sales (2020-2031) & (K Pcs)
 Figure 17. Global Metabotropic Glutamate Receptor 1 Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Metabotropic Glutamate Receptor 1 Report Years Considered
 Figure 19. Metabotropic Glutamate Receptor 1 Sales Share by Manufacturers in 2024
 Figure 20. Global Metabotropic Glutamate Receptor 1 Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Metabotropic Glutamate Receptor 1 Players: Market Share by Revenue in Metabotropic Glutamate Receptor 1 in 2024
 Figure 22. Metabotropic Glutamate Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Metabotropic Glutamate Receptor 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2020-2031)
 Figure 25. North America Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2020-2031)
 Figure 29. Europe Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2020-2031)
 Figure 37. China Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Metabotropic Glutamate Receptor 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Metabotropic Glutamate Receptor 1 by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Metabotropic Glutamate Receptor 1 by Type (2020-2031)
 Figure 59. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Metabotropic Glutamate Receptor 1 by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Metabotropic Glutamate Receptor 1 by Application (2020-2031)
 Figure 62. Global Metabotropic Glutamate Receptor 1 Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Metabotropic Glutamate Receptor 1 Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Neuromorphic Computing Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4J6287
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Metabotropic Glutamate Receptor (MRG) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10D7404
Tue Sep 02 00:00:00 UTC 2025

Add to Cart

Global Neuromorphic AI Semiconductor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-30S7280
Thu Jul 24 00:00:00 UTC 2025

Add to Cart

Global Cognitive Neuroscience Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22S12458
Mon Jul 07 00:00:00 UTC 2025

Add to Cart